Medical facilities nationwide are increasingly confronted with the challenge of providing the best healthcare for their patients while managing the mounting costs of that care. Healthcare costs associated with the treatment of patients whose conditions require repeated clinical admissions for intravenous (IV) drug delivery are significant. These admissions involve high-cost medications, staff, materials, and administration for treatment that may be more efficiently delivered outside a clinical setting by the patient or caregiver.

Subcutaneous delivery provides patients with the option to take medicines that are usually administered via the IV route but with the convenience and economy of at-home treatment. This flexibility has the potential to afford patients greater independence and personal comfort while reducing the institutional burden of inpatient treatment.

At scPharmaceuticals we believe that by extending the reach of subcutaneous drug delivery, we can elevate patient care and reduce overall healthcare costs.

See what’s in our pipeline